ALS Fighter Cai Lei’s Big Data Crusade for a Cure
After his 2019 ALS diagnosis, former e-commerce exec Cai Lei launched a big data platform, body donation drive, and a global expert network to fast-track a cure.
ALS
Read More
Neuralink Empowers Seven Patients with Mind-Controlled Implants
Neuralink’s N1 implant reaches seven recipients, enabling thought-controlled device use for ALS and spinal injuries. Explore the tech, trials, and ethical hurdles shaping mind-machine interfaces.
Medicine Without Borders: CGTN Health Talk on Global ALS Breakthroughs
Neuroscientists from the Chinese mainland, the U.S. and Germany unite on CGTN’s Health Talk to share ALS treatment breakthroughs and push for global cooperation and equitable access.
Racing Against Time: Cai Lei’s Fight on Global ALS/MND Awareness Day
On Global ALS/MND Awareness Day, former exec Cai Lei opens up about his ALS diagnosis and advocacy journey, spotlighting research breakthroughs and community-driven hope in the fight against ALS.
Everyday Heroes: Resilience on Global ALS/MND Awareness Day
On Global ALS/MND Awareness Day, we highlight stories of courage: an AI-voiced patient, a devoted caregiver expanding lives, and global research uniting experts in the fight against ALS.
Biogen Launches First Gene-Targeted ALS Therapy in the Chinese Mainland
Biogen has launched Tofersen, the Chinese mainland’s first gene-targeted therapy for SOD1-ALS, offering hope by slowing motor neuron damage in a disease fatal within 3-5 years.